• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Luiro

Head of Nordic ER Development, Analyst

Antti Luiro portrait

Coverage

LeadDeskNightingale HealthAiforia TechnologiesQt Group

Latest content

ShowingAll content types

LeadDesk Q2'26 preview: Forbedret rentabilitet forventes trods faldende omsætning

Analyst Comment 13.08.2026, 07.07 by Frans-Mikael Rostedt, Antti Luiro
LeadDesk

Qt Group Q2'26: Markedet begynder at røre på sig

Research 07.08.2026, 06.30 by Antti Luiro, Atte Riikola
Qt Group

Qt Group Q2'26 - hurtig kommentar: Retningen forbedres hurtigere end forventet

Analyst Comment 06.08.2026, 08.06 by Antti Luiro, Atte Riikola
Qt Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Qt Group Q2'26 preview: Indtjeningsvæksten fortsætter med at være midlertidig et stykke tid endnu

Analyst Comment 05.08.2026, 07.58 by Antti Luiro, Atte Riikola
Qt Group

Aiforia secured a 20 MEUR financing agreement with the EIB

Analyst Comment 03.08.2026, 08.19 by Antti Siltanen, Antti Luiro
Aiforia Technologies

Aiforia indicatively agreed on a 20 MEUR financing facility with the EIB

Analyst Comment 16.06.2026, 08.16 by Antti Siltanen, Antti Luiro
Aiforia Technologies

Nightingale: We factored the project delay into our estimates

Research 12.06.2026, 09.20 by Antti Siltanen, Antti Luiro
Nightingale Health

Qt's restruktureringsforhandlinger i Finland er afsluttet

Analyst Comment 05.06.2026, 07.34 by Antti Luiro
Qt Group

Qt Group Q1'26: Aktien handles stadig med frygt i front

Research 15.05.2026, 07.57 by Antti Luiro
Qt Group

M&A activity in digital pathology is increasing

Analyst Comment 15.05.2026, 08.45 by Antti Siltanen, Antti Luiro
Aiforia Technologies